Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-05 · accession 0001493152-24-049195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-09 | 2024-12-05 | IMDX | James Andrea S. | CFO | P - Purchase | $2.29 | +20.0K | 53.7K | +59% | +$45.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2024-12-05 | P | A | 20,000 | $2.29 | 53,670 | D | — | — |